CLVS Price Targets and Analyst Ratings NASDAQ:CLVS
CLVS Forecast. What You Should Know.
CLVS Historical Ratings and Targets
About Clovis Oncology
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.